Contact

Representative before the EPO

Employment test 1 - 10 employees
Company dna konig szynka tilmann von renesse
operating since 1997
Headquarter in Munich and 1 office
active in Legal Services and IP Portfolio Processing

We have observed 4 EP applications Lars Hemsath has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 15, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13739973

NOVEL THERAPEUTIC TREATMENTS WITH ANTI-HER2 ANTIBODIES HAVING A LOW FUCOSYLATION

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/32
Applicant:
Glycotope GmbH
Agent:
Lars Hemsath, König Szynka Tilmann von Renesse Patentanwälte Partnerschaft mbB
Status:
EXAMINATION IN PROGRESS
EP14724007

ANTI-CANCER TREATMENTS WITH ANTI-EGFR ANTIBODIES HAVING A LOW FUCOSYLATION

IPC classification:
A61K 39/00, C07K 16/28
Applicant:
Glycotope GmbH
Agent:
Lars Hemsath, König Szynka Tilmann von Renesse Patentanwälte Partnerschaft mbB
Status:
EXAMINATION REQUESTED
EP16168841

IMPROVED RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE

IPC classification:
A61K 38/00, A61K 38/24, C07K 14/435, C07K 14/59
Applicant:
Glycotope GmbH
Agent:
Lars Hemsath, König Szynka Tilmann von Renesse Patentanwälte Partnerschaft mbB
Status:
EXAMINATION REQUESTED
EP15719165

CONTROLLED OVARIAN HYPERSTIMULATION WITH IMPROVED RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE

IPC classification:
A61K 38/24, A61P 15/08
Applicant:
Glycotope GmbH
Agent:
Lars Hemsath, König Szynka Tilmann von Renesse Patentanwälte Partnerschaft mbB
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature